Replies to post #733714 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

Chiugray,

You dug much deeper on this regard than I did. I treat a lot of stuff I don't understand as black box. My intuitive thinking is that if they can pulse DCs with peptides related to brain tumor, they can also pulse DCs with peptides related to other diseases. But my understanding is superficial. I feel fun to think this way.

A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma
https://clinicaltrials.gov/study/NCT06342908

Vaccine Therapy in Treating Patients With Malignant Glioma
https://clinicaltrials.gov/study/NCT00612001

Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients
https://pmc.ncbi.nlm.nih.gov/articles/PMC3317661/

Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients
https://pmc.ncbi.nlm.nih.gov/articles/PMC3568250/